Why the study?
Does a pharmacoinvasive strategy combining thrombolysis and liberal PCI yield comparable survival rates to primary PCI in patients with STEMI?
Does a pharmacoinvasive strategy combining thrombolysis and liberal PCI yield comparable survival rates to primary PCI in patients with STEMI?
A pharmacoinvasive strategy combining thrombolysis with liberal PCI provides comparable early and 1-year survival to primary PCI for STEMI patients treated early.
May support pharmacoinvasive strategy when timely PPCI unavailable; leaves open need for randomized confirmation.
When used early after the onset of symptoms, a pharmacoinvasive strategy that combines thrombolysis with a liberal use of PCI yields early and 1-year survival rates that are comparable to those of PPCI.
No takes yet. Share an insight, caveat, or question.
Danchin et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: